EP Patent

EP2640362B2 — Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate

Assigned to Janssen Sciences Ireland ULC · Expires 2021-12-01 · 4y expired

What this patent protects

Patent listed against Emtriva.

Drugs covered by this patent

Patent Metadata

Patent number
EP2640362B2
Jurisdiction
EP
Classification
—
Expires
2021-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Sciences Ireland ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.